Načítá se...
Type I IFN drives experimental SLE by distinct mechanisms in CD4 T cells and B cells
Myriad studies have linked type I interferon (IFN) to the pathogenesis of autoimmune diseases, including systemic lupus erythematosus (SLE). While increased levels of type I IFN are found in patients with SLE, and IFN blockade ameliorates disease in many mouse models of lupus, its precise roles in d...
Uloženo v:
| Vydáno v: | Immunohorizons |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7294741/ https://ncbi.nlm.nih.gov/pubmed/32161059 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/immunohorizons.2000005 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|